Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. - Girmens,JF.; Erginay,A.; Massin,P. (Am J Ophthalmol, 2003)